Home/Publication/Concord Biotech Debuts on India’s Stock Exchanges
Concord Biotech Debuts on India’s Stock Exchanges 

21 Aug 2023

US$ 19.00

Concord Biotech Ltd (Concord Biotech), a biopharmaceutical company backed by Quadria Capital (Quadria), was listed on...

Price / article: US$19.00
OR existing subscriber
Related Publications

Granite Asia has led a US$60 m series A funding round in the US-based Centific Global Solutions Inc (Centific), an AI...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.